The Senate Resolution No. by Senators Talbot, Bass, and McMath urges the Louisiana Department of Health to conduct a study on the potential impacts of prohibiting pharmacy benefit manager (PBM) ownership of pharmacies in the state. The resolution highlights concerns regarding vertical integration in healthcare, where companies manage health plans, pharmacy benefit management, and pharmacy operations, leading to reduced competition, higher costs, and limited patient choices. The resolution emphasizes the need for a comprehensive analysis to understand how such a prohibition could affect patient access, employer-sponsored health plans, and the overall provision of pharmacy services.

The study requested by the resolution is to be submitted to the legislature by March 1, 2026, and should include various aspects such as cost implications for plan sponsors, the impact on Medicare pharmacy network adequacy, potential employment changes, and patient access to medications. Additionally, it will assess the capacity of non-prohibited pharmacies to accommodate displaced patients and the potential costs associated with prescription non-compliance for Medicaid. The resolution aims to provide a thorough understanding of the implications of PBM ownership on the healthcare landscape in Louisiana.